Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
ABV On Other Exchanges
Symbol
Exchange
Venture
OTC US
All times are local (Market data is delayed by at least 15 minutes).

algae biosciences corp (ABV) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ALGAE BIOSCIENCES CORP (ABV)

Related News

No related news articles were found.

algae biosciences corp (ABV) Related Businessweek News

No Related Businessweek News Found

algae biosciences corp (ABV) Details

Algae Biosciences Corporation, a development stage biotechnology company, engages in the research, development, manufacture, and sale of micro and macro algae products nutraceuticals, food additives, and pharmaceuticals markets in the United States. The company primarily offers whole algae powders, algae oils, and de-fatted algae meal. Its products are primarily used as nutraceuticals, nutritional supplements, and therapeutic proteins; as dyes in diagnostic tests and biotechnology; as biofuels; and in personal care and cosmetics products. The company’s products are also used for aquaculture and animal consumption, food additives, and functional foods. Algae Biosciences Corporation was founded in 2002 and is headquartered in Scottsdale, Arizona.

Founded in 2002

algae biosciences corp (ABV) Top Compensated Officers

Chief Executive Officer, Secretary and Direct...
Total Annual Compensation: --
Interim Chief Financial Officer and Director
Total Annual Compensation: --
Executive
Total Annual Compensation: --
Executive
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

algae biosciences corp (ABV) Key Developments

Algae Biosciences Corporation Primary Exchange Listing will Change to (TSX Venture Exchange - Nex: ABV.H) from (TSX Venture Exchange: ABV)

Effective January 07, 2014, Algae Biosciences Corporation primary exchange listing will change to (TSX Venture Exchange - Nex: ABV.H) from (TSX Venture Exchange: ABV).

Algae Biosciences Corporation To Move From TSX Venture To NEX

In accordance with TSX Venture Policy 2.5, Algae Biosciences Corporation has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective on January 7, 2014, the company's listing will transfer to NEX, the company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Calgary to NEX. Further to the TSX Venture Exchange Bulletin dated October 3, 2013, trading in the company's securities will remain suspended. Members are prohibited from trading in the securities of the company during the period of the suspension or until further notice.

Algae Biosciences Corporation Announces Executive Changes

Algae Biosciences Corporation announced that Mr. Andrew Ayers has resigned as President, CEO and director of the company and its subsidiary, effective immediately. Mr. Ayers has served as President, CEO and director of the company since foundation. Additionally, the company announced that Mr. Robert Thompson has resigned as CFO and director of the company and its subsidiary, effective immediately. The company announced that Mr. Ward Marlatte has been appointed CEO, secretary and director of the company. Additionally, Mr. Marc Stachiw has been appointed interim CFO and director of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABV:CN C$0.00 CAD 0.00

ABV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ABV.
View Industry Companies
 

Industry Analysis

ABV

Industry Average

Valuation ABV Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 0.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALGAE BIOSCIENCES CORP, please visit www.algaebio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.